Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 16, 2012 | Juventas Therapeutics | $22.2M Series B | Triathlon Medical Ventures | Early Stage Partners, Fletcher Spaght Ventures, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Venture Investors |